ROLDAN Trademark

Trademark Overview

On Friday, April 7, 2023, a trademark application was filed for ROLDAN with the United States Patent and Trademark Office. The USPTO has given the ROLDAN trademark a serial number of 97878568. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 13, 2025. This trademark is owned by Laboratorios Roldan, C. por A.. The ROLDAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
roldan

General Information

Serial Number97878568
Word MarkROLDAN
Filing DateFriday, April 7, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, February 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of six navy blue letters spelling the word ROLDAN in which the initial letter R extends under the following letter O and L.
Indication of Colors claimedThe color(s) navy blue is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 13, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLaboratorios Roldan, C. por A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMiami, FL 33172

Trademark Events

Event DateEvent Description
Tuesday, April 11, 2023NEW APPLICATION ENTERED
Tuesday, May 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 3, 2024ASSIGNED TO EXAMINER
Monday, April 29, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, January 13, 2024NON-FINAL ACTION WRITTEN
Saturday, January 13, 2024NON-FINAL ACTION E-MAILED
Saturday, January 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 29, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, July 12, 2024NOTICE OF REVIVAL - E-MAILED
Friday, July 12, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, July 12, 2024PETITION TO REVIVE-GRANTED
Friday, July 12, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 12, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 15, 2024FINAL REFUSAL E-MAILED
Sunday, September 15, 2024FINAL REFUSAL WRITTEN
Sunday, September 15, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, December 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, December 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 13, 2025NON-FINAL ACTION E-MAILED
Thursday, February 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 13, 2025NON-FINAL ACTION WRITTEN

Related Keywords

roldan development products pharmaceutical